Cortical Labs Launches CL1, the First Commercial Biological Computer
Cortical Labs has made its CL1 platform commercially available, allowing researchers and developers to deploy code to living human neurons grown on silicon chips. The system offers dramatically lower power use and is accessible via cloud 'Wetware as a Service'.
TLDR
Australian company Cortical Labs has begun shipping the CL1, described as the world's first code-deployable biological computer. It integrates lab-grown human neurons on a chip with life-support systems, enabling adaptive computation through electrical feedback. The platform is now available for purchase or remote access.
Technical Approach
Neurons are induced from adult human cells and grown on a multi-electrode array. Game states or data inputs are translated to stimulation patterns; the cells' activity drives outputs. Learning occurs via closed-loop feedback, similar to reinforcement learning but using real biological plasticity. The system includes integrated life-support (pumps, gas, temperature) to keep neurons viable for months.
Power efficiency is orders of magnitude better than silicon equivalents for certain adaptive tasks.
Commercial Rollout
Cortical Labs is selling CL1 units (priced around US$35,000) and offering Cortical Cloud for remote experimentation without on-site hardware. Early users include research labs exploring energy-efficient AI alternatives, drug discovery, and novel interfaces. The work builds on earlier DishBrain experiments.
Why this story matters
Biological computing moves from proof-of-concept to product. If it scales, it could complement or disrupt traditional AI hardware in niches requiring extreme efficiency or biological-like adaptability. It also surfaces new ethical and safety questions around using living tissue for computation.
Sources
- Cortical Labs CL1 product page and announcements (corticallabs.com/cl1, March 2026)
- Company statements on commercial availability and cloud service
- Coverage in The Guardian, The Register, and other outlets on the CL1 launch and demonstrations (March 2026)
- Investor and research partner statements (e.g., Gobi Partners March 2026)